Julio Delgado
ORCID: 0000-0002-5157-4376Also affiliated with Fundació Clínic per a la Recerca Biomèdica, Universitat de Barcelona
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial”.
Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak +14 more
Fabian Arenas, Romina Royo, Ariadna Giró, Irene López-Oreja, Marta Aymerich +9 more
Guillem Clot, Ferran Nadeu, Renée Beekman, Tycho Baumann, Jessica Nordlund +27 more
Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson +34 more
Berta Pons-Brun, Núria Russiñol, Heribert Playà-Albinyana, Tycho Baumann, Martí Duran‐Ferrer +25 more